Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Psychopharmacology

Psychopharmacology is the scientific study of the effects drugs have on mood, sensation, thinking, and behaviour. We can explore these effects in preclinical models, in healthy volunteers and patients, by studying the effects of drug levels on symptoms, protein levels in blood, and biomarkers such as EEG. Nowdays novel imaging techniques play an important role in studying psychopharmacology.

We have recently completed a number of pharmacokinetic and safety studies with the following drugs:

  • Ibogaine and noribogaine, potential treatments for opioid addiction
  • Ketamine

We have ongoing biomarker, pharmacokinetic and safety studies in the following areas:

  • Ketamine in anxiety and depression
  • Ketamine biomarkers
  • Biomarkers of various anti-anxiety drug classes
  • Benzoic acid in patients with chronic schizophrenia

To find out more about these studies visit the Clinical Trials section

Key researcher: